Abstract
The present invention relates to the use of one or more cannabinoids in the manufacture of medicaments for use in the treatment of diseases and conditions benefiting from inverse agonism of the CB1 and / or the CB2 cannabinoid receptor. Preferably the cannabinoid is a cannabidiol (CBD) type compound or derivative thereof .
| Original language | English |
|---|---|
| Patent number | WO200713822 |
| IPC | A61K31/05; A61K31/352; A61P19/08; |
| Publication status | Published - 6 Dec 2007 |